Try our beta test site

German Spondyloarthritis Inception Cohort (GESPIC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2017 by Charite University, Berlin, Germany
Sponsor:
Collaborators:
German Federal Ministry of Education and Research (BMBF): 2000-2007 and 2010-current
2010-current: AbbVie (Abbott)
Amgen
Centocor, Inc.
Schering-Plough
Wyeth is now a wholly owned subsidiary of Pfizer
2015-current: Berlin Institute of Health (BIH)
Information provided by (Responsible Party):
Denis Poddubnyy, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01277419
First received: January 14, 2011
Last updated: March 11, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2020
  Estimated Primary Completion Date: July 2020 (Final data collection date for primary outcome measure)
Publications: